Bank of New York Mellon’s Bioventus BVS Stock Holding History

Bank of New York Mellon’s Portfolio BVS Stock Details BVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.44M	Buy	152,316 +8,407	+6%	+$80.3K	﹤0.01%	3147
2026 Q1	$1.31M	Sell	143,909 -6,193	-4%	-$51.9K	﹤0.01%	3050
2025 Q4	$1.12M	Buy	150,102 +18,382	+14%	+$132K	﹤0.01%	3173
2025 Q3	$881K	Sell	131,720 -3,507	-3%	-$24.3K	﹤0.01%	3277
2025 Q2	$895K	Buy	135,227 +15,178	+13%	+$108K	﹤0.01%	3193
2025 Q1	$1.1M	Sell	120,049 -5,006	-4%	-$50K	﹤0.01%	3015
2024 Q4	$1.31M	Buy	125,055 +34,036	+37%	+$403K	﹤0.01%	2977
2024 Q3	$1.09M	Sell	91,019 -21,458	-19%	-$186K	﹤0.01%	3093
2024 Q2	$647K	Buy	+112,477	New	+$617K	﹤0.01%	3437
2024 Q1	–	Sell	-15,042	Closed	-$79.3K	–	4180
2023 Q4	$79.3K	Sell	15,042 -77,251	-84%	-$306K	﹤0.01%	4123
2023 Q3	$305K	Buy	92,293 +3,434	+4%	+$12K	﹤0.01%	3791
2023 Q2	$257K	Sell	88,859 -94,334	-51%	-$181K	﹤0.01%	3896
2023 Q1	$196K	Sell	183,193 -10,050	-5%	-$19.2K	﹤0.01%	3933
2022 Q4	$504K	Sell	193,243 -16,023	-8%	-$70K	﹤0.01%	3535
2022 Q3	$1.47M	Buy	209,266 +10,099	+5%	+$79.1K	﹤0.01%	3023
2022 Q2	$1.36M	Buy	199,167 +45,460	+30%	+$464K	﹤0.01%	3049
2022 Q1	$2.17M	Buy	153,707 +4,382	+3%	+$58.7K	﹤0.01%	2885
2021 Q4	$2.16M	Buy	149,325 +90,694	+155%	+$1.29M	﹤0.01%	2942
2021 Q3	$830K	Buy	58,631 +41,113	+235%	+$633K	﹤0.01%	3504
2021 Q2	$308K	Buy	17,518 +1,417	+9%	+$22.8K	﹤0.01%	3957
2021 Q1	$246K	Buy	+16,101	New	+$229K	﹤0.01%	3987

Other funds holding BVS

EWM

Essex Woodlands Management The Woodlands, Texas $254M AUM 4.59% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

HIM

Hillsdale Investment Management Toronto, Ontario, Canada $4.39B AUM 72.96% 1-Year Est. Return

Prudential Financial Newark, New Jersey $91.8B AUM 38.24% 1-Year Est. Return

TAM

Tocqueville Asset Management New York $7.56B AUM 44.87% 1-Year Est. Return

KOCAA

Knights of Columbus Asset Advisors New Haven, Connecticut $2B AUM 42.86% 1-Year Est. Return

Bank of New York Mellon's BVS Position: Q2 2026 in Review

Bank of New York Mellon increased its Bioventus (BVS) stake by 5.8% in Q2 2026, buying an estimated $80.3K and bringing the position to 152,316 shares worth $1.44M. The position accounts for ﹤0.01% of the portfolio, ranked #3147.

Bank of New York Mellon first reported a position in BVS in Q1 2021 and has held it in 21 quarters since. The position peaked at $2.17M in Q1 2022. 82 funds tracked by Wall St. Rank hold BVS as of Q2 2026.

Bank of New York Mellon held 152,316 shares of Bioventus worth $1.44M as of Q2 2026.
Bank of New York Mellon bought 8,407 Bioventus shares in Q2 2026, an estimated $80.3K.
Bioventus made up ﹤0.01% of Bank of New York Mellon's portfolio in Q2 2026, its #3147 holding.
Bank of New York Mellon first reported a position in Bioventus in Q1 2021 and has held it in 21 quarters since.
Bank of New York Mellon's Bioventus position peaked at $2.17M in Q1 2022.
82 funds tracked by Wall St. Rank held Bioventus as of Q2 2026.

Based on Bank of New York Mellon's 13F filing for Q2 2026, filed 6 Aug 2026.